The optimization of the parameters for the various classifiers was done by using grid search with PR curve as scoring performance measure for selecting best parameter. As our data is 1 8 2 imbalanced, it is very important to select the parameters that show balanced precision and After applying supervise learning to classify samples, we visualised the distribution of 1 8 6 samples based on selected features on reduced dimensions using t-SNE (t-Distributed to analyze the high-dimensional data. It converts multi-dimensional data to two or more Identification of important features using simple threshold based approach 1 9 2
Here, we employed MCC (Matthews correlation coefficient) based feature selection threshold is assigned to metastatic tumor if it is downregulated in metastatic tumor samples 1 9 7
otherwise as primary tumor sample and vice versa. We compute performance of each given 1 9 8 feature and identify features having highest performance in term of MCC with minimum 1 9 9 difference in sensitivity and specificity. In present study, both internal and external validation techniques were employed to evaluate 2 0 2 the performance of models. Here, primarily main dataset has been subdivided into two 2 0 3 subsets i.e. training dataset and independent or external validation dataset in ratio of 80:20.
0 4
We used 80% of the main dataset for training and remaining 20% for independent validation. First, the training dataset is used for developing model and for performing ten-fold cross 2 0 6 validation as internal validation. In this ten-fold cross validation technique, training dataset is 2 0 7 randomly splits into ten sets; of which nine out of ten sets were used as training sets and the 2 0 8 remaining tenth set as testing dataset. This process is repeated ten times in such a way that 2 0 9 each set is exploited once for testing. The final performance of model is the mean 2 1 0 performance of all the ten sets. In order to avoid optimization of parameters in case of ten-
fold cross-validation, we also implement external validation. In case of external validation, 2 1 2 we evaluate our model on an independent or external dataset not used for training. In order to 2 1 3 measure performance of models, we used standard parameters. Both threshold-dependent and threshold-independent parameters were employed to measure the performance. In case of threshold-dependent parameters, we measure sensitivity, specificity, accuracy and Matthew's 2 1 6 correlation coefficient (MCC) using following equations. While, for threshold-independent measures, we used standard parameter Area under the 2 2 7
Receiver Operating Characteristic curve (AUROC). The AUROC curve is generated by 2 2 8 plotting sensitivity or true positive rate against the false positive rate (1-specificity) at various thresholds. Finally, the area under AUROC curve calculated to compute a single parameter In order to discern the biological relevance of the signature genes, enrichment analysis is 2 3 3 performed using Enrichr (Kuleshov et al., 2016 target genes of signature miRNA. In current study, we have analysed the RNA-seq, miRNA-seq, methylation-seq data of patients containing expression of 20,502 genes was used to select relevant features using two features using WEKA-FCBF and SVC-L1 respectively. We applied six machine learning 2 5 2 algorithms on the selected features obtained using above two methods. As shown in Table 1 , Interestingly, model based on 140 features selected using WEKA-FCBF attained similar As we analysed the new tumour event (NTE) clinical file of SKCM patients, we observed tumour events. Therefore, we remove or exclude these 16 samples from dataset and again Table S1 ).
7 0
Enrichment analysis shows the biological role of the RNA signature in carcinogenesis. and Weinberg, 2011). feature selection method) on training and independent validation dataset to classify metastatic 2 7 9 from primary tumor samples applying various machine-learning algorithms (classifiers). 78.95% primary samples of validation dataset were correctly predicted ( Table 2 ). The mean samples of validation dataset (Table 3) . These 5 miRNAs include hsa-mir-205, hsa-mir-
218.2, hsa-mir-513a.1, hsa-mir-675 and hsa-mir-7974.
9 5
Among these signatures, hsa-mir-205 targets various genes (identified from miRTarBase) To ascertain the role of epigenetics in progression of melanoma from primary to metastatic,
we have taken average methylation value for each gene as described in methods. Firstly, 38
and 2 features were selected using WEKA-FCBF and SVC-L1 respectively. Subsequently,
classification models were developed using 38 features and it can be observed (in Table 4 Visualization of samples
As we observed that RNA expression based features are performing quite well as compared
to miRNA expression and methylation profiling, we visualised the 17 RNA expression 3 3 2 features using tSNE. The Figure 3 shows that primary tumors (P1) form the separate cluster differ from P1 but some of them merges/co-clustered with P1 which is quite expected as P1
progresses to P2 ( Figure 3A ). The tSNE analysis shows a clear distinction between P1 and M1 ( Figure 3B ) with some of the primary samples going extreme into the boundaries of M1. Primary tumors as shown in Figure 3C . Finally the visualization of these seventeen features
in three dimensional space in all the four classes is shown in (Figure 3E ). These analyses Next, in order to compile information from individual models developed using all the three
types of genomic features, we developed ensemble method. In the ensemble method, dataset respectively (Table 5 ). The primary tumors (P1) are localised lesions and P2 includes the samples with in transit 3 6 3 metastasis and satellite metastasis which represents intra-lymphatic tumour which has not 3 6 4 still spread to lymphatic nodes. We selected 10 features using SVC-L1 (as in the above 3 6 5 models RNA-seq data selected appropriate number of features using SVC-L1) and the results 3 6 6 of classification models on these 10 features shows that it is difficult to classify the samples Table S2 ). The selected ten
features is shown in column 1 of heatmap (Figure 4 ). Further we tried to classify tumors that have invaded lymphatic nodes from primary tumors.
3 7 9
Our analysis shows these tumors can be classified with high precision. As SVC-W based of training data. We also observed the fair sensitivity of 95.56% and specificity of 90.48% with metastasis in comparison to the primary or localized tumor (Table 6 ). Next, we tried to classify the distant metastatic tumors (M2) from primary tumors (P1).
Surprisingly classification of these two groups of samples is not as good as lymphatic node dataset (Supplementary Table S3 ). To differentiate between the tumors which have spread to lymph nodes (M1) and regional Table S4 ). Further, we developed model to categorize the tumors which spread to lymph nodes or Table S5 ).
0 9
The Figure 4 shows the various signatures that are associated for discrimination primary Single feature based classification model using RNA and miRNA expression
Our goal is to develop single feature based classification models to segregate metastatic and upregulated in metastatic) is higher than a threshold value otherwise it is primary sample. In 4 2 3 these models, threshold is varied incrementally from minimum to maximum RESM value.
2 4
Finally, that threshold is selected which have maximum MCC in classifying metastatic and of maximum MCC and minimum difference in sensitivity and specificity to assess the ability 4 2 7
of each feature to classify metastatic and primary samples (Supplementary Table S6 ). Table   4 2 8 S6 represents 20 mRNAs and 2 miRNA that can distinguish two types of samples with high Among them C7 is upregulated in metastatic samples that reveals its role as oncogenesis in As from the above analysis we can observe that 17 RNAs and miRNA hsa-mir-205 have Table S7 ). Performance of this hybrid model is almost similar with marginal increase in To contribute the scientific community, we developed a web server, CancerSPP (Skin Cancer Biol Cell 22, 4068-4078.
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